Where can I buy Zolbetuximab-Vyloy? How to obtain medicines and precautions
Zolbetuximab (Zolbetuximab)-Vyloy is a new type of targeted antibody drug mainly used to treat locally advanced unresectable or metastatic HER2-negative gastric cancer and gastroesophageal junction (GEJ) adenocarcinoma, especially those patients who are Claudin 18.2 (CLDN18.2) positive. This drug selectively destroys cancer cells by targeting the Claudin 18.2 protein. It is an innovative targeted therapy drug with significant potential in the field of cancer treatment. Due to its excellent efficacy in clinical trials, zotuximab has gradually attracted the attention of doctors and patients at home and abroad.

At present, the original drug of zotuximab has been approved in many countries, especially in Europe and Japan, where the original drug is already available. In China, zotuximab has only recently entered the market. Although some domestic hospitals have begun to introduce the drug, due to its short time on the market, it has not yet been widely used. Therefore, when patients want to purchase zotuximab, they need to pay special attention to the purchase method and legality of the drug.
In China, the purchase of zotuximab mainly relies on hospitals and pharmacies. Usually, patients need to purchase it through a professional hospital pharmacy. Hospital pharmacies can often provide formal drug sales channels and ensure the authenticity and safety of drugs. Before patients buy drugs, they usually need a prescription from a doctor and decide whether to use the drug and the appropriate dosage based on the doctor's advice.
In addition to hospital pharmacies, some domestic drug supply platforms or online pharmacies may also provide zotuximab purchase services. However, patients need to pay special attention to the fact that many drug purchase platforms do not provide sales of zotuximab, especially when generic drugs are not yet on the market, and purchase channels are relatively limited. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
Reference: https://medlineplus.gov/druginfo/meds/a624072.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)